RNA vaccines are leading the way in vaccines because they are particularly well suited to rapid development.Although no RNA vaccine has yet been approved, the threat of a pandemic is a great incentive to accelerate its progress.RNA vaccines consist of mrna strands.They are injected into the body, usually wrapped in lipid nanoparticles.They fuse with cells.Once inside the cell, the RNA sequence is translated by the ribosome into a protein or part of a protein.
This report contains market size and forecasts of COVID-19 RNA Vaccine in Global, including the following market information:
- Global COVID-19 RNA Vaccine Market Size 2024-2030, ($ millions)
- The global COVID-19 RNA Vaccine market is projected to reach US$ million by 2029.
We surveyed the COVID-19 RNA Vaccine companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global COVID-19 RNA Vaccine Market, by Type, 2024-2030 ($ millions)
Global COVID-19 RNA Vaccine Market Segment Percentages, by Type
- Being Developed
- Preclinical
- Clinical I
- Clinical II
Global COVID-19 RNA Vaccine Market, by Application, 2024-2030 ($ millions)
Global COVID-19 RNA Vaccine Market Segment Percentages, by Application
- Pharmaceutical And Biotechnology Companies
- Hospital
- Academic And Research Organizations
- Other
Global COVID-19 RNA Vaccine Market, By Region and Country, 2024-2030 ($ Millions)
Global COVID-19 RNA Vaccine Market Segment Percentages, by region and country
- United States
- Europe
- Asia
- China
- Rest of World
- Competitor Analysis
The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include:
- MODERNA
- CureVac
- Zydus Cadila
- BioNTech
- Stermirna
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 COVID-19 RNA Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global COVID-19 RNA Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global COVID-19 RNA Vaccine Overall Market Size
2.1 Global COVID-19 RNA Vaccine Market Size: 2023 VS 2030
2.2 Global COVID-19 RNA Vaccine Market Size, Prospects & Forecasts: 2023-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Key COVID-19 RNA Vaccine Players in Global Market
3.2 Global Companies COVID-19 RNA Vaccine Product & Technology
4 COVID-19 RNA Vaccine Companies Profiles
4.1 MODERNA
4.1.1 MODERNA Company Summary
4.1.2 MODERNA Business Overview
4.1.3 MODERNA COVID-19 RNA Vaccine Product Offerings & Technology
4.1.4 MODERNA COVID-19 RNA Vaccine R&D, and Plans
4.2 CureVac
4.2.1 CureVac Company Summary
4.2.2 CureVac Business Overview
4.2.3 CureVac COVID-19 RNA Vaccine Product Offerings & Technology
4.2.4 CureVac COVID-19 RNA Vaccine R&D, and Plans
4.3 Zydus Cadila
4.3.1 Zydus Cadila Company Summary
4.3.2 Zydus Cadila Business Overview
4.3.3 Zydus Cadila COVID-19 RNA Vaccine Product Offerings & Technology
4.3.4 Zydus Cadila COVID-19 RNA Vaccine R&D, and Plans
4.4 BioNTech
4.4.1 BioNTech Company Summary
4.4.2 BioNTech Business Overview
4.4.3 BioNTech COVID-19 RNA Vaccine Product Offerings & Technology
4.4.4 BioNTech COVID-19 RNA Vaccine R&D, and Plans
4.5 Stermirna
4.5.1 Stermirna Company Summary
4.5.2 Stermirna Business Overview
4.5.3 Stermirna COVID-19 RNA Vaccine Product Offerings & Technology
4.5.4 Stermirna COVID-19 RNA Vaccine R&D, and Plans
5 Sights by Region
5.1 By Region - Global COVID-19 RNA Vaccine Market Size, 2024 & 2030
5.2 By Region - Global COVID-19 RNA Vaccine Revenue, (2024-2030)
5.3 United States
5.3.1 Key Players of COVID-19 RNA Vaccine in United States
5.3.2 United States COVID-19 RNA Vaccine Development Current Situation and Forecast
5.4 Europe
5.4.1 Key Players of COVID-19 RNA Vaccine in Europe
5.4.2 Europe COVID-19 RNA Vaccine Development Current Situation and Forecast
5.5 China
5.5.1 Key Players of COVID-19 RNA Vaccine in China
5.5.2 China COVID-19 RNA Vaccine Development Current Situation and Forecast
5.6 Rest of World
6 Sights by Product
6.1 By Type - Global COVID-19 RNA Vaccine Market Size Markets, 2024 & 2030
6.2 Being Developed
6.3 Preclinical
6.4 Clinical I
6.5 Clinical II
7 Sights by Application
7.1 By Application - Global COVID-19 RNA Vaccine Market Size, 2024 & 2030
7.2 Pharmaceutical And Biotechnology Companies
7.3 Hospital
7.4 Academic And Research Organizations
7.5 Other
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. COVID-19 RNA Vaccine Market Opportunities & Trends in Global Market
Table 2. COVID-19 RNA Vaccine Market Drivers in Global Market
Table 3. COVID-19 RNA Vaccine Market Restraints in Global Market
Table 4. Key Players of COVID-19 RNA Vaccine in Global Market
Table 5. Global Companies COVID-19 RNA Vaccine Product & Technology
Table 6. MODERNA Company Summary
Table 7. MODERNA COVID-19 RNA Vaccine Product Offerings
Table 8. CureVac Company Summary
Table 9. CureVac COVID-19 RNA Vaccine Product Offerings
Table 10. Zydus Cadila Company Summary
Table 11. Zydus Cadila COVID-19 RNA Vaccine Product Offerings
Table 12. BioNTech Company Summary
Table 13. BioNTech COVID-19 RNA Vaccine Product Offerings
Table 14. Stermirna Company Summary
Table 15. Stermirna COVID-19 RNA Vaccine Product Offerings
Table 16. By Region? Global COVID-19 RNA Vaccine Revenue, (US$, Mn), 2024 & 2030
Table 17. By Region - Global COVID-19 RNA Vaccine Revenue, (US$, Mn), 2024-2030
Table 18. By Type ? Global COVID-19 RNA Vaccine Market Size, (US$, Mn), 2024 & 2030
Table 19. By Application? Global COVID-19 RNA Vaccine Market Size, (US$, Mn), 2024 & 2030
List of Figures
Figure 1. COVID-19 RNA Vaccine Segment by Type in 2030
Figure 2. COVID-19 RNA Vaccine Segment by Application in 2030
Figure 3. Global COVID-19 RNA Vaccine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global COVID-19 RNA Vaccine Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global COVID-19 RNA Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. By Region - Global COVID-19 RNA Vaccine Revenue Market Share, 2024-2030
Figure 8. By Type - Global COVID-19 RNA Vaccine Revenue Market Share, 2024-2030
Figure 9. By Application - Global COVID-19 RNA Vaccine Revenue Market Share, 2024-2030
